Allogene Therapeutics, Inc. Escrow Deposit
Allogene Therapeutics, Inc. (ALLO) had Escrow Deposit of $0 as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Assets
us-gaap:EscrowDeposit · last filed 2026-08-12
- 2026-06-30: Escrow Deposit $0.00.
- 2026-03-31: Escrow Deposit $0.00.
- 2025-12-31: Escrow Deposit $23.48M.
- 2025-09-30: Escrow Deposit $23.47M.
| Period end | Escrow Deposit |
|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-12 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-13 |
| 2025-12-31 | $23.48M 10-Q · filed 2026-08-12 |
| 2025-09-30 | $23.47M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $23.48M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $21.64M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $20.77M 10-K · filed 2026-03-12 |
| 2024-09-30 | $22.32M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $21.43M 10-Q · filed 2024-08-07 |
| 2023-12-31 | $0.00 10-K · filed 2025-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| Aura Biosciences, Inc. (AURA) | United States | $0.639B | -5.61 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |